Company attributes
Location
Founder
Pitchbook URL
Parent Organization
Spun Out From
Investors
Founded Date
2020
A joint venture between BridgeBio Pharma and Maze Therapeutics, focused on transforming and advancing breakthrough precision medicine approaches designed to treat cardiovascular disease
Timeline
No Timeline data yet.